home / stock / tyra / tyra quote
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $0.02 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 06-14-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 06-13-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 06-12-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 06-11-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 06-07-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 06-06-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 06-05-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 06-01-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 05-31-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 05-29-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 05-28-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 05-25-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 05-24-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 05-23-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 05-22-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 05-21-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 05-18-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 05-17-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 05-16-2018 |
$ | $N/A | $0.02 | $N/A | $N/A | 0 | 05-15-2018 |
News, Short Squeeze, Breakout and More Instantly...
Tyra Biosciences Inc. Company Name:
TYRA Stock Symbol:
OTCMKTS Market:
Tyra Biosciences Inc. Website:
Tyra Biosciences Announces Preclinical Proof-of-Concept Results with TYRA-300 in Hypochondroplasia (HCH) PR Newswire - In a preclinical HCH model, TYRA-300 demonstrated increases in long bone length and binding against the HCH altered protein - -TYRA remain...
Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights PR Newswire - TYRA-300 on track in ACH and oncology; SURF301 Ph1 initial results and ACH IND submission expected in 2H24 - - Cash, cash equivalents, and marketable securities of $382.5 milli...
Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors PR Newswire CARLSBAD, Calif. , May 7, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnolog...